Clinical trial
A Randomized Controlled Study to Evaluate the Safety and Efficacy of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Anterior STEMI Patients With TIMI 0-2 at Presentation.
NCT05497011 is registered in ClinicalTrials.gov with Miracor Medical SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Study to Evaluate the Safety and Efficacy of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Anterior STEMI Patients With TIMI 0-2 at Presentation.
- Lead sponsor
- Miracor Medical SA
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- March 30, 2023
- Completion date
- June 30, 2028
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anterior wall myocardial infarction, stemi - st elevation myocardial infarction